Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Busque

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 12, 2018
Native kidney cytomegalovirus nephritis and cytomegalovirus prostatitis in a kidney transplant recipientSusanna K Tan, Xingxing S Cheng, Chia-Sui Kao, et al.
The New England Journal of Medicine|January 25, 2008
Tolerance and chimerism after renal and hematopoietic-cell transplantationJohn D Scandling, Stephan Busque, Sussan Dejbakhsh-Jones, et al.
Clinical Transplantation|January 22, 2005
A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipientsJeffrey S Zaltzman, Anne Boucher, Stephan Busque, et al.
Clinical Transplantation|April 28, 2006
Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantationIrene W Y Ma, Hannah A Valantine, Atsuko Shibata, et al.
JAMA Network Open|March 10, 2022
Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017Xingxing S Cheng, Jialin Han, Jennifer L Braggs-Gresham, et al.
Transplantation|June 26, 2007
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipientsSander Florman, Rita Alloway, Munci Kalayoglu, et al.
Transplantation Direct|September 21, 2018
Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension TrialStephan Busque, Flavio G Vincenti, Helio Tedesco Silva, et al.
Transplantation|November 26, 2009
Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetilDavid N Rush, Sandra M Cockfield, Peter W Nickerson, et al.
Transplantation Direct|January 26, 2023
Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease PatientsCary M Looney, Aaron Schroeder, Erica Tavares, et al.
Medical Care|June 18, 2024
The Medical Costs of Determining Eligibility and Waiting for a Kidney TransplantationKunyao Xu, Avi Dor, Suman Mohanty, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 12, 2018
Native kidney cytomegalovirus nephritis and cytomegalovirus prostatitis in a kidney transplant recipientSusanna K Tan, Xingxing S Cheng, Chia-Sui Kao, et al.
The New England Journal of Medicine|January 25, 2008
Tolerance and chimerism after renal and hematopoietic-cell transplantationJohn D Scandling, Stephan Busque, Sussan Dejbakhsh-Jones, et al.
Clinical Transplantation|January 22, 2005
A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipientsJeffrey S Zaltzman, Anne Boucher, Stephan Busque, et al.
Clinical Transplantation|April 28, 2006
Validation of a screening protocol for identifying low-risk candidates with type 1 diabetes mellitus for kidney with or without pancreas transplantationIrene W Y Ma, Hannah A Valantine, Atsuko Shibata, et al.
JAMA Network Open|March 10, 2022
Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017Xingxing S Cheng, Jialin Han, Jennifer L Braggs-Gresham, et al.
Transplantation|June 26, 2007
Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipientsSander Florman, Rita Alloway, Munci Kalayoglu, et al.
Transplantation Direct|September 21, 2018
Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension TrialStephan Busque, Flavio G Vincenti, Helio Tedesco Silva, et al.
Transplantation|November 26, 2009
Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetilDavid N Rush, Sandra M Cockfield, Peter W Nickerson, et al.
Transplantation Direct|January 26, 2023
Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease PatientsCary M Looney, Aaron Schroeder, Erica Tavares, et al.
Medical Care|June 18, 2024
The Medical Costs of Determining Eligibility and Waiting for a Kidney TransplantationKunyao Xu, Avi Dor, Suman Mohanty, et al.
Pageof 4